NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00474929 2019-08-20Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaMayo ClinicPhase 1/2 Completed103 enrolled 12 charts
NCT00687674 2019-08-20Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaMayo ClinicPhase 1 Terminated13 enrolled 7 charts
NCT01183663 2016-06-03Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)M.D. Anderson Cancer CenterPhase 1 Completed180 enrolled
NCT00536575 2013-02-27Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma PatientsSCRI Development Innovations, LLCPhase 1/2 Completed13 enrolled 5 charts